See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

They Discover a Mixture of Drugs that Improves Survival in Patients with Prostate Cancer

Summary by 20minutos
An international trial in which the Vall d'Hebron Institute of Oncology (VHIO) of Barcelona has participated has shown that the combination of thalazoparib and enzalutamide involves a "significant" improvement in survival in patients with castration-resistant metastatic prostate cancer. This is announced this Friday by the VHIO in a statement, in which the results of the phase 3 clinical trial called TALAPRO-2, which has been conducted in 142 ce…

3 Articles

20minutos20minutos
Reposted by
MM MedicalMM Medical
Center

They Discover a Mixture of Drugs that Improves Survival in Patients with Prostate Cancer

An international trial in which the Vall d'Hebron Institute of Oncology (VHIO) of Barcelona has participated has shown that the combination of thalazoparib and enzalutamide involves a "significant" improvement in survival in patients with castration-resistant metastatic prostate cancer. This is announced this Friday by the VHIO in a statement, in which the results of the phase 3 clinical trial called TALAPRO-2, which has been conducted in 142 ce…

·Madrid, Spain
Read Full Article
diarioestrategia.cldiarioestrategia.cl

A Combination of Drugs Improves the Survival of a Type of Prostate Cancer in a Trial

The Vhio participates in an international study with 142 centers from 26 countries ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

diarioestrategia.cl broke the news in on Friday, July 25, 2025.
Sources are mostly out of (0)

Similar News Topics

Barcelona icon

Barcelona

News
For You
SearchBlindspotLocal